Comparison of Treatment Effect of Chinese Medicine and Western Medicine on Depression in China and America

March 16, 2012 updated by: Xue Yan, Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Comparison of different assessment methods to evaluate the treatment efficacy of Chinese medicine on minor and mild depression.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Significant differences show on the evaluation of treatment efficacy of Chinese medicine on depression in China and America. Choose minor and mild depression patients as trials. One hundred and sixty trials will be included and randomly divided into Chinese medicine group (n=40), acupuncture group (n=40), traditional Chinese medicine psychology group (n=40) and physical treatment group (n=40). Time points of assessment are before treatment, 1 week, 2 weeks, 4weeks, 6 weeks and 12 weeks post treatment.The assessment tools are series of psychological questionnaires. And study the mechanism of treatment efficacy assessment variances by different methods.

Study Type

Interventional

Enrollment (Anticipated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Weidong Wang, Master
  • Phone Number: 86-10-88001261
  • Email: pro_wwd@sohu.com

Study Contact Backup

Study Locations

  • China
    • Beijing
      • Beijing, Beijing, China, 100053

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • According with ICD-10 criteria of depression;
  • Age 16-70;
  • Antidepressant and other Psychiatric drugs have not been had two weeks before the trial, or the drugs above had been used but have cleaning period of two weeks;
  • Level of education is higher than junior middle school;
  • Course of disease is more than two weeks;
  • Volunteer to join and Signed the informed consent

Exclusion Criteria:

  • Pregnancy or lactation;
  • Severe depression or have serious suicidal tendencies
  • long distance or other causes who can not adherence to treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Psychotherapy
Other: Psychotherapy
Thought Imprint Psychotherapy under lower Resistance State
Experimental: acupuncture
Procedure: acupuncture
six acupuncture point including DU20, EX HN3, EX HN1, PC6,HT7,SP6,special for depression
Experimental: physiotherapy
Device: Transcranial magnetic stimulation
Give magnetic stimulation at head
Experimental: Chinese herb
Chinese herbs special for depression
Drug: Chinese herbs
Chinese herbs special for depression

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
psychological questionnaires
Time Frame: 12 weeks post treatment.
12 weeks post treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Collaborators

Massachusetts General Hospital
California Pacific Medical Center Research Institute

Investigators

  • Study Chair: Weidong Wang, master, Guang'anmen hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2012

Primary Completion (Anticipated)

March 1, 2014

Study Completion (Anticipated)

July 1, 2014

Study Registration Dates

First Submitted

March 2, 2012

First Submitted That Met QC Criteria

March 16, 2012

First Posted (Estimate)

March 20, 2012

Study Record Updates

Last Update Posted (Estimate)

March 20, 2012

Last Update Submitted That Met QC Criteria

March 16, 2012

Last Verified

March 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2011DFA30960

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Chinese herbs

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe